Hi Tony,
Slide 7 from the latest presentation clearly indicates that the cancer vaccine is front and centre in future development plans. Hayes also indicated in the conference call that he is fielding a lot of enquiries in relation to immuno-oncology and the role that our FPPs can play. Whether this refers to the cancer vaccine work is unclear but we will undoubtedly hear a lot more about FPPs and immunotherapy inside the cell.
A collaboration with Big Pharma in relation to an immuno-oncology target will be an incredibly important validation and could indeed be company making - it could well be a vaccine.
Hi Tony, Slide 7 from the latest presentation clearly indicates...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.020(1.59%) |
Mkt cap ! $743.6M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.28 | $1.24 | $46.67K | 37.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15857 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |